Literature DB >> 26438600

Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.

Hyunbae Kim1, Roberto Mendez1, Xuequn Chen2, Deyu Fang3, Kezhong Zhang4.   

Abstract

Cyclic AMP-responsive element-binding protein 3-like 3, hepatocyte specific (CREBH), is a hepatic transcription factor that functions as a key regulator of energy homeostasis. Here, we defined a regulatory CREBH posttranslational modification process, namely, lysine-specific acetylation, and its functional involvement in fasting-induced hepatic lipid metabolism. Fasting induces CREBH acetylation in mouse livers in a time-dependent manner, and this event is critical for CREBH transcriptional activity in regulating hepatic lipid homeostasis. The histone acetyltransferase PCAF-mediated acetylation and the deacetylase sirtuin-1-mediated deacetylation coexist to maintain CREBH acetylation states under fasting conditions. Site-directed mutagenesis and functional analyses revealed that the lysine (K) residue at position 294 (K294) within the bZIP domain of the CREBH protein is the site where fasting-induced acetylation/deacetylation occurs. Introduction of the acetylation-deficient (K294R) or acetylation-mimicking (K294Q) mutation inhibited or enhanced CREBH transcriptional activity, respectively. Importantly, CREBH acetylation at lysine 294 was required for the interaction and synergy between CREBH and peroxisome proliferator-activated receptor α (PPARα) in activating their target genes upon fasting or glucagon stimulation. Introduction of the CREBH lysine 294 mutation in the liver leads to hepatic steatosis and hyperlipidemia in animals under prolonged fasting. In summary, our study reveals a molecular mechanism by which fasting or glucagon stimulation modulates lipid homeostasis through acetylation of CREBH.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26438600      PMCID: PMC4648819          DOI: 10.1128/MCB.00665-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

Review 1.  The interaction of hepatic lipid and glucose metabolism in liver diseases.

Authors:  Lars P Bechmann; Rebekka A Hannivoort; Guido Gerken; Gökhan S Hotamisligil; Michael Trauner; Ali Canbay
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

2.  Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation.

Authors:  H L Hung; A Y Kim; W Hong; C Rakowski; G A Blobel
Journal:  J Biol Chem       Date:  2001-01-11       Impact factor: 5.157

3.  The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism.

Authors:  Jung Hoon Lee; Petros Giannikopoulos; Stephen A Duncan; Jian Wang; Christopher T Johansen; Jonathan D Brown; Jorge Plutzky; Robert A Hegele; Laurie H Glimcher; Ann-Hwee Lee
Journal:  Nat Med       Date:  2011-06-12       Impact factor: 53.440

4.  Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism.

Authors:  Ferdinand von Meyenn; Thomas Porstmann; Emanuel Gasser; Nathalie Selevsek; Alexander Schmidt; Ruedi Aebersold; Markus Stoffel
Journal:  Cell Metab       Date:  2013-02-14       Impact factor: 27.287

5.  Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes.

Authors:  Yoshimi Nakagawa; Aoi Satoh; Sachiko Yabe; Mika Furusawa; Naoko Tokushige; Hitomi Tezuka; Motoki Mikami; Wakiko Iwata; Akiko Shingyouchi; Takashi Matsuzaka; Shiori Kiwata; Yuri Fujimoto; Hidehisa Shimizu; Hirosuke Danno; Takashi Yamamoto; Kiyoaki Ishii; Tadayoshi Karasawa; Yoshinori Takeuchi; Hitoshi Iwasaki; Masako Shimada; Yasushi Kawakami; Osamu Urayama; Hirohito Sone; Kazuhiro Takekoshi; Kazuto Kobayashi; Shigeru Yatoh; Akimitsu Takahashi; Naoya Yahagi; Hiroaki Suzuki; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Endocrinology       Date:  2014-09-18       Impact factor: 4.736

6.  Measurement of ER stress response and inflammation in the mouse model of nonalcoholic fatty liver disease.

Authors:  Ze Zheng; Chunbin Zhang; Kezhong Zhang
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

7.  Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.

Authors:  Chunbin Zhang; Guohui Wang; Ze Zheng; Krishna Rao Maddipati; Xuebao Zhang; Gregory Dyson; Paul Williams; Stephen A Duncan; Randal J Kaufman; Kezhong Zhang
Journal:  Hepatology       Date:  2012-02-09       Impact factor: 17.425

8.  Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.

Authors:  Hyunbae Kim; Roberto Mendez; Ze Zheng; Lin Chang; Juan Cai; Ren Zhang; Kezhong Zhang
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

Review 9.  The growing landscape of lysine acetylation links metabolism and cell signalling.

Authors:  Chunaram Choudhary; Brian T Weinert; Yuya Nishida; Eric Verdin; Matthias Mann
Journal:  Nat Rev Mol Cell Biol       Date:  2014-08       Impact factor: 94.444

10.  PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse.

Authors:  Peter V Hornbeck; Jon M Kornhauser; Sasha Tkachev; Bin Zhang; Elzbieta Skrzypek; Beth Murray; Vaughan Latham; Michael Sullivan
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

View more
  18 in total

1.  Toll-like Receptor (TLR) Signaling Interacts with CREBH to Modulate High-density Lipoprotein (HDL) in Response to Bacterial Endotoxin.

Authors:  Aditya Dandekar; Yining Qiu; Hyunbae Kim; Jiemei Wang; Xia Hou; Xuebao Zhang; Ze Zheng; Roberto Mendez; Fu-Shin Yu; Ashok Kumar; Deyu Fang; Fei Sun; Kezhong Zhang
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

2.  Hepatocyte-specific Sirt6 deficiency impairs ketogenesis.

Authors:  Lei Chen; Qinhui Liu; Qin Tang; Jiangying Kuang; Hong Li; Shiyun Pu; Tong Wu; Xuping Yang; Rui Li; Jinhang Zhang; Zijing Zhang; Ya Huang; Yanping Li; Min Zou; Wei Jiang; Tao Li; Meng Gong; Lu Zhang; Hua Wang; Aijuan Qu; Wen Xie; Jinhan He
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

Review 3.  Sensing and signaling mechanisms linking dietary methionine restriction to the behavioral and physiological components of the response.

Authors:  Laura A Forney; Kirsten P Stone; Desiree Wanders; Thomas W Gettys
Journal:  Front Neuroendocrinol       Date:  2017-12-21       Impact factor: 8.606

4.  Deficiency of the Mitochondrial NAD Kinase Causes Stress-Induced Hepatic Steatosis in Mice.

Authors:  Kezhong Zhang; Hyunbae Kim; Zhiyao Fu; Yining Qiu; Zhao Yang; Jiemei Wang; Deqiang Zhang; Xin Tong; Lei Yin; Jing Li; Jianmei Wu; Nathan R Qi; Sander M Houten; Ren Zhang
Journal:  Gastroenterology       Date:  2017-09-18       Impact factor: 22.682

5.  Interaction between stress responses and circadian metabolism in metabolic disease.

Authors:  Zhao Yang; Hyunbae Kim; Arushana Ali; Ze Zheng; Kezhong Zhang
Journal:  Liver Res       Date:  2017-09

6.  CREBH Maintains Circadian Glucose Homeostasis by Regulating Hepatic Glycogenolysis and Gluconeogenesis.

Authors:  Hyunbae Kim; Ze Zheng; Paul D Walker; Gregory Kapatos; Kezhong Zhang
Journal:  Mol Cell Biol       Date:  2017-06-29       Impact factor: 4.272

7.  Regulation of hepatic autophagy by stress-sensing transcription factor CREBH.

Authors:  Hyunbae Kim; Dreana Williams; Yining Qiu; Zhenfeng Song; Zhao Yang; Victoria Kimler; Andrew Goldberg; Ren Zhang; Zengquan Yang; Xuequn Chen; Li Wang; Deyu Fang; Jiandie D Lin; Kezhong Zhang
Journal:  FASEB J       Date:  2019-03-26       Impact factor: 5.191

8.  HRD1-ERAD controls production of the hepatokine FGF21 through CREBH polyubiquitination.

Authors:  Juncheng Wei; Lu Chen; Fei Li; Yanzhi Yuan; Yajun Wang; Wanjun Xia; Yuehui Zhang; Yuanming Xu; Zhao Yang; Beixue Gao; Chaozhi Jin; Johanna Melo-Cardenas; Richard M Green; Hui Pan; Jian Wang; Fuchu He; Kezhong Zhang; Deyu Fang
Journal:  EMBO J       Date:  2018-11-02       Impact factor: 11.598

9.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

Review 10.  Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.

Authors:  Oriol Juanola; Sebastián Martínez-López; Rubén Francés; Isabel Gómez-Hurtado
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.